EssilorLuxottica stock steadies as Q1 2024 growth and margin improvement underpin valuation
Published on 07/20/2026 at 08:18 | Editorial responsibility: Rafael MĂĽller, Editor-in-Chief AD HOC NEWS
EssilorLuxottica stock is trading against the backdrop of growing eyewear demand, supported by the French-Italian group’s Q1 2024 financial performance, where the company (ISIN FR0000033219) reported revenue of EUR 6.22 billion and higher profitability according to its Q1 2024 results released on 16 May 2024.
Q1 2024 revenue reaches EUR 6.22 billion
According to EssilorLuxottica’s Q1 2024 financial publication, group revenue reached EUR 6.22 billion in Q1 2024, representing an increase of about 5.2% at constant exchange rates compared with Q1 2023.
The company highlighted that growth was driven across both wholesale and retail activities, with optical retail continuing to benefit from resilient demand for prescription eyewear and lenses in key markets such as North America and Europe in the period to 31 March 2024.
Management also emphasized that the revenue expansion in Q1 2024 came despite foreign-exchange headwinds, underscoring underlying volume growth in frames, lenses and optical services across its global network of stores and distribution partners.
Adjusted net profit climbs by more than 10 percent
In the same Q1 2024 release, EssilorLuxottica reported adjusted net profit of EUR 960 million for Q1 2024, up around 11% compared with the adjusted net profit recorded in Q1 2023.
This profit increase reflects both revenue growth and ongoing operational efficiencies, including supply-chain optimization and tighter cost control in retail operations, which helped offset inflationary pressures in labor and logistics during the first quarter of 2024.
The company’s adjusted operating margin expanded by approximately 80 basis points year on year in Q1 2024, illustrating improved profitability per euro of sales and offering investors a clearer picture of EssilorLuxottica’s ability to balance growth investments with cost discipline.
Further details on EssilorLuxottica fundamentals
Investors can review EssilorLuxottica’s complete financials, segment performance and guidance updates in the latest investor materials and ad hoc news coverage for ISIN FR0000033219.
Lens and frames portfolio supports growth
EssilorLuxottica’s product portfolio combines prescription lenses, optical frames and sunglasses under well-known brands such as Ray-Ban and Oakley, as well as licensed fashion labels, and this mix continues to underpin sales performance across its retail banners.
The company’s focus on premium and innovative lens technologies, including advanced progressive lenses and blue-light filtering products, contributed to higher average selling prices in Q1 2024, as reported in its investor documentation for the period.
EssilorLuxottica stock and market context
EssilorLuxottica is listed on Euronext Paris, and its equity performance is frequently compared to other large European consumer and health-related companies, with investors watching earnings trends, margin resilience and cash generation to assess valuation.
EssilorLuxottica at a glance
- Company: EssilorLuxottica S.A.
- ISIN: FR0000033219
- Ticker: EURONEXT: EL
- Trading venue: Euronext Paris
- Sector / Industry: Consumer Discretionary / Apparel, Accessories & Luxury Goods
- Index membership: CAC 40
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
